Preeclampsia Postpartum
14
5
8
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
21%
3 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Aspirin and Preeclampsia
Biomarkers in Management of Post Partum Preeclampsia
Vascular Effects of High-Salt After Preeclampsia
Optimizing Preeclampsia Postpartum With Point-of-care Ultrasound
Postpartum Low-Dose Aspirin and Preeclampsia
MR and Inflammation After Preeclampsia
Preeclampsia And Nonsteroidal Drugs for Analgesia: a Randomized Non Inferiority Trial
Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women
Preeclampsia Educational Program Study (PrEPS)
A Community Health Worker Intervention to Address Adverse Pregnancy Outcomes
Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia
Losartan for Improved Vascular Endothelial Function After Preeclampsia
Aspirin for Postpartum Patients With Preeclampsia
Effects of Vitamin C Administration on Extravascular Lung Water in Patients With Severe Features of Preeclampsia